Delivered as an oral presentation at the Triological Society Combined Sections Meeting, Miami, Florida, U.S.A., January 26–28, 2012.
Oromandibular dystonia: Long-term management with botulinum toxin
Article first published online: 5 OCT 2013
Copyright © 2013 The American Laryngological, Rhinological and Otological Society, Inc.
Volume 123, Issue 12, pages 3078–3083, December 2013
How to Cite
Sinclair, C. F., Gurey, L. E. and Blitzer, A. (2013), Oromandibular dystonia: Long-term management with botulinum toxin. The Laryngoscope, 123: 3078–3083. doi: 10.1002/lary.23265
Dr. Blitzer has received funding from and is a consultant for Allergan, Inc., Merz Pharmaceuticals, and Revance. The authors have no other funding, financial relationships, or conflicts of interest to disclose.
- Issue published online: 25 NOV 2013
- Article first published online: 5 OCT 2013
- Manuscript Accepted: 3 FEB 2012
- Manuscript Revised: 30 JAN 2012
- Manuscript Received: 12 JAN 2012
This article has been cited by:
- 1An Update on the Use of Botulinum Toxin Therapy in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2015, 15, 1, , ,
- 2Bone and cartilage changes in rabbit mandibular condyles after 1 injection of botulinum toxin, American Journal of Orthodontics and Dentofacial Orthopedics, 2015, 148, 6, 999, , , ,
- 3Botulinum toxin in masticatory muscles of the adult rat induces bone loss at the condyle and alveolar regions of the mandible associated with a bone proliferation at a muscle enthesis, Bone, 2015, 77, 75, , ,
- 4Levodopa-induced lateral jaw deviation dystonia, Parkinsonism & Related Disorders, 2015, 21, 7, 808, ,